Forsman, Jonas http://orcid.org/0000-0002-8473-6327
Taipale, Heidi
Masterman, Thomas
Tiihonen, Jari
Tanskanen, Antti
Funding for this research was provided by:
Psykiatrifonden
Article History
Received: 29 March 2019
Accepted: 4 June 2019
First Online: 19 June 2019
Compliance with ethical standards
:
: HT, JT, and AT have participated in research projects funded by Janssen-Cilag and Eli Lilly, with grants paid to the institution where they were employed. AT is a member of the Janssen-Cilag advisory board. JT has served as a consultant to the European Medical Agency and the Finnish Medicines Agency and has received lecture fees from Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka, and grants from the Stanley Foundation and the Sigrid Jusélius Foundation. JF and TM have received a grant from Psykiatrifonden (Stockholm, Sweden). All studied pharmacological products in this paper were generic substances without exclusive ownership by any company.
: The funding source had no role in the design or execution of the study; in the collection, management, analysis, or interpretation of the data; in the preparation, review or approval of the manuscript; or in the decision to submit the manuscript for publication.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. In this registry-based postmortem study, all personal information was anonymized, rendering unnecessary the need for formal consent or ethical approval. The study was nonetheless reviewed and approved by the Regional Ethical Review Board in Stockholm (2013/1411-31/5).